MediPal Holdings Corporation (TYO:7459)

MediPal Holdings Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	81,844	76,734	74,741	70,061	57,284
Depreciation & Amortization	28,193	18,417	17,982	14,648	14,338
Loss (Gain) From Sale of Assets	850	675	848	413	131
Loss (Gain) From Sale of Investments	-20,818	-11,787	-8,511	-6,855	922
Loss (Gain) on Equity Investments	-3,907	3,768	-3,584	-3,590	-3,484
Other Operating Activities	-25,447	-22,348	-21,676	-22,658	-7,845
Change in Accounts Receivable	-42,715	-5,361	-23,053	-5,364	-10,283
Change in Inventory	-11,727	-6,121	-779	-2,274	-3,739
Change in Accounts Payable	49,214	8,103	27,766	-25,687	8,262
Change in Other Net Operating Assets	-8,935	-1,521	-1,891	-2,548	5,630
Operating Cash Flow	46,552	60,559	61,843	16,146	61,216
Operating Cash Flow Growth	-23.13%	-2.08%	283.02%	-73.63%	77.71%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-6,619	-8,861	-15,560	-10,483	-15,958
Sale of Property, Plant & Equipment	158	394	44	213	255
Cash Acquisitions	-12,700	-4,703	-858	-41,097	-
Divestitures	-	232	-	1,000	-
Sale (Purchase) of Intangibles	-3,068	-3,570	-3,835	-3,021	-2,919
Investment in Securities	26,800	14,190	9,471	17,033	-5,927
Other Investing Activities	4,735	-986	2,919	-3,142	-112
Investing Cash Flow	9,299	-3,363	-7,817	-39,494	-24,343

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Repaid	-	-	-	-30,000	-350
Total Debt Repaid	-	-	-	-30,000	-350
Net Debt Issued (Repaid)	-	-	-	-30,000	-350
Repurchase of Common Stock	-8,088	-5,070	-10,090	-1	-1
Common Dividends Paid	-13,225	-12,539	-11,179	-9,658	-8,818
Other Financing Activities	-8,084	-8,338	-3,979	-3,882	-7,302
Financing Cash Flow	-29,397	-25,947	-25,248	-43,541	-16,471

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	6	3	-	-	-
Miscellaneous Cash Flow Adjustments	742	-	5,744	-	1
Net Cash Flow	27,202	31,252	34,522	-66,889	20,403

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	39,933	51,698	46,283	5,663	45,258
Free Cash Flow Growth	-22.76%	11.70%	717.29%	-87.49%	109.47%
Free Cash Flow Margin	1.05%	1.41%	1.30%	0.17%	1.38%
Free Cash Flow Per Share	194.03	247.96	218.54	26.18	202.84
Levered Free Cash Flow	49,719	34,848	34,893	-11,891	34,970
Unlevered Free Cash Flow	49,727	34,852	34,898	-11,869	34,980

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	13	10	5	34	16
Cash Income Tax Paid	25,804	23,651	24,298	24,709	9,620
Change in Working Capital	-14,163	-4,900	2,043	-35,873	-130

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error